Pharmafile Logo

First Edition Translations Ltd

Founded in 1981, First Edition Translations Ltd is one of the UK’s oldest established translation agencies and a founder member of the Institute of Translation and Interpreting. Our team of professional medical translators are fluent in over 30 languages, ensuring your documents and materials are accurately translated.

First Edition offers diverse medical translation services that cover a broad range of materials, including:
Regulatory and legal documents
SPCs, PILs, labelling, treatment manuals
Clinical trials, assessments
Research studies, papers and abstracts
Information, manufacturing and marketing materials, IFUs
Specialist published materials, including catalogues, industry magazines and newsletters
Websites, apps and software

We value accuracy, reliability and outstanding quality, making us a trusted partner for all your medical and pharmaceutical translations. Adhering to the ISO 17100 standard, we can provide certification for our work upon request. If you’d like further advice, our friendly and multilingual project management team is always happy to help.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Atlas Translations Ltd

With Atlas Translations Ltd you get a service that is both personal and professional. This means that your message will be understood in the language and context you need it…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Company Details

6 Wellington Court, Wellington Street, Cambridge, CB1 1HZ, United Kingdom
+44 (0)1223 356 733

 Latest Content from PMHub 

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.To find out more about Impetus: https://www.meetwithimpetus.comImpetus Digital...

The speed of science and the pace of comms

Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes.

Virtual Patient Engagement Program: A Customer Story

Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease...

Putting Skin in the Game at AAD 2023

AAD has wrapped up in New Orleans, and the Medscape team have returned home from another successful conference.During the conference, Medscape hosted one educational symposium, Reframing the Management Approach for...

Humancomms for humancare?

Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023

Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery

Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve...

Wrapping up EAU with a Look at Medscape’s Urology Impact

The Medscape Education Global team has returned from EAU in Milan, Italy, having presented an educational symposium and a networking event with Urology faculty and supporters.The educational symposium, Harnessing the...

Webcast: Evolving Patient Journeys – How to generate deeper insights in a changing healthcare landscape

Watch part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years.

How to create content for health professionals

Press Releases | March 20, 2023 | Springer Nature

Catching the attention of time-strapped healthcare professionals is hard, but not impossible.

The challenges of reimbursement and innovative pricing for cell and gene therapies

Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...